Moderna advances two vax candidates against Omicron variants
The company is one of a number of vaccine makers developing new shots to tackle BA.4 and BA.5
Moderna is moving ahead with two Omicron vaccine candidates for the third quarter of the year.
One is designed against the BA.1 variant and another against BA.4 and BA.5.